Advertisement
News
Subscribe to MDT Magazine News

Healthcare M & A Industry, Investment Leaders Head to America's Healthcare Silicon Valley for iiBIG Finance Forum

January 5, 2011 5:45 am | by The Associated Press | Comments

http://www.iibig.com/F1101 () —iiBIG returns to "America's Healthcare Silicon Valley" to present the industry-leading Investment and M&A Opportunities in Healthcare, January 25-26, 2011, at the Nashville Convention Center in Nashville, Tennessee. As experts are predicting an increase in...

Sliding commodities depress TSX; U.S. markets lower amid positive jobs data

January 5, 2011 5:45 am | by Malcolm Morrison-Associated Press | Comments

Lower commodity stocks helped push the Toronto stock market lower Wednesday as oil prices fell back despite data showing a larger than forecast drop in U.S. oil consumption.The S&P/TSX composite index lost 77.1 points to 13,325.21 as gold prices also further deteriorated as more positive...

Cell Biosciences Launches New Platform for Multiplex Western Blot Detection

January 5, 2011 5:35 am | by Bio-Medicine.Org | Comments

SANTA CLARA, Calif., Jan. 5, 2011 /- Cell Biosciences, Inc., a provider of innovative protein analysis tools to life science researchers, today announced the launch of the latest addition to their premier line of next-generation imaging products, the FluorChem® M MultiFluor system....

TOPICS:
Advertisement

BD Announces Webcast of Annual Meeting of Shareholders

January 5, 2011 5:35 am | by Bio-Medicine.Org | Comments

FRANKLIN LAKES, N.J., Jan. 5, 2011 /- BD (Becton, Dickinson and Company) (NYSE: BDX ), a global medical technology company, announced today that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday, February 1, 2011, at 1 p.m. (ET). The webcast can be accessed from...

TOPICS:

SuperNova Diagnostics® to Present at Biotech Showcase™ 2011 During J.P. Morgan Healthcare Conference January 10-13

January 5, 2011 5:34 am | by Bio-Medicine.Org | Comments

WASHINGTON, LONDON and HONG KONG, Jan. 5, 2011 /- SuperNova Diagnostics®, Inc., a privately-held global diagnostics company for human and non-human health applications, announced today that Neil J. Campbell, president and CEO, will present at Biotech Showcase 2011 in conjunction with...

TOPICS:

Helena Laboratories to Manage BIS and OFAC Screening via ATTUS WatchDOG® Pro

January 5, 2011 5:34 am | by Bio-Medicine.Org | Comments

CHARLOTTE, N.C., Jan. 5, 2011 /- ATTUS Technologies, Inc , adds Helena Laboratories, a clinical laboratory instrument and reagent manufacturer, to the growing list of global companies choosing the market leading WatchDOG® Pro for their BIS, OFAC and other watch list screening...

TOPICS:

Elekta's MOSAIQ Oncology Information System Named Category Leader in '2010 Top 20 Best in KLAS Awards' Report

January 5, 2011 5:34 am | by Bio-Medicine.Org | Comments

ATLANTA, Jan. 5, 2011 /- Elekta's MOSAIQ® Oncology Information System (OIS)—the market's leading open-system, vendor-neutral OIS—has earned the No. 1 ranking in the oncology software category from KLAS, an independent research firm. According to KLAS, a Category Leader...

TOPICS:

Estrogen May Help Precancerous Cells Spread in Oral Cavity

January 5, 2011 5:33 am | by AACR | Comments

PHILADELPHIA - Head and neck cancer is the sixth most common type of cancer and is on the rise in some demographic groups, including young women without any known risk factors. Now, researchers at Fox Chase Cancer Center report that estrogen may increase the movement of precancerous cells...

TOPICS:
Advertisement

Federal Register: Draft Guidance for Industry and FDA; Establishing the Performance Characteristics of Nucleic Acid-Based In Vitro Diagnostic Devices for the Detection and Dif...

January 5, 2011 5:30 am | by U.S. Food & Drug Administration | Comments

The draft guidance document provides industry and Agency staff with updated recommendations for studies to establish the analytical and clinical performance of nucleic acid-based in vitro diagnostic devices (IVDs) intended for the detection and...

TOPICS:

Labtiva lands $2M for research software

January 5, 2011 4:38 am | by Mass High Tech: The Journal of New England Technology | Comments

Software developer Labtiva Inc., a company at startup incubator Dogpatch Labs in Cambridge, has secured $2 million in equity financing, according to a regulatory filing. The company is developing research management tools for the life sciences and academic literature industries.

Hamilton CapTel® and Partner TV Ears to Display Telephone Communication Technology Designed for Individuals with Hearing Loss at Consumer Electronics Show

January 5, 2011 3:35 am | by Bio-Medicine.Org | Comments

AURORA, Neb., Jan. 5, 2011 /- Consumer Electronics Show Las Vegas Convention Center Booth #2910. For the first time, Hamilton CapTel ® will demonstrate the CapTel 800i® captioned telephone for more than 100,000 attendees at the Consumer Electronics Show (CES) in Las Vegas...

TOPICS:

Water Street Healthcare Partners Acquires OraPharma, Inc.

January 5, 2011 3:34 am | by Bio-Medicine.Org | Comments

CHICAGO, Jan. 5, 2011 /- Water Street Healthcare Partners announced today that it has acquired OraPharma, Inc. from Johnson & Johnson.  Water Street, a strategic private equity firm focused exclusively on health care, plans to build OraPharma into a leading specialty...

TOPICS:

DJO Incorporated Acquires Manufacturer of Compression Therapy Products, Elastic Therapy, Inc.

January 5, 2011 3:34 am | by Bio-Medicine.Org | Comments

SAN DIEGO, Jan. 5, 2011 /- DJO Incorporated ("DJO" or the "Company"), a global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced the acquisition of Elastic Therapy, Inc. (ETI). The acquisition closed yesterday, January 4,...

TOPICS:

New Sub-Analysis of RE-LY Trial Examines Pradaxa in Patients with Atrial Fibrillation Undergoing Cardioversion

January 5, 2011 3:33 am | by Bio-Medicine.Org | Comments

RIDGEFIELD, Conn., Jan. 5, 2011 /- Results of a post-hoc analysis of the RE-LY® trial among patients with non-valvular atrial fibrillation (NVAF) undergoing cardioversion, a treatment to convert an abnormal heartbeat back to normal sinus rhythm, were published online on Jan. 3 in...

TOPICS:

InterMune to Present at J.P. Morgan Healthcare Conference

January 5, 2011 3:33 am | by Bio-Medicine.Org | Comments

BRISBANE, Calif., Jan. 5, 2011 /- InterMune, Inc. (Nasdaq: ITMN ) today announced that Dan Welch, Chairman, Chief Executive Officer and President of InterMune, will present at the 29th Annual J.P. Morgan Healthcare Conference in San Francisco on January 12, 2011, at 4:30 p.m. EST / 1:30...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading